ONCO
Onconetix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.02
+38.02%Sep 3, 2026, 12:30 UTC
Onconetix entered into a definitive agreement to acquire Realbotix LLC, a subsidiary of Realbotix Corp.
Source:Aug 6, 2026, 12:30 UTC
Realbotix, the acquisition target of Onconetix, secured an agreement with a streaming platform to feature its humanoid robot in an upcoming episode of an Emmy-winning series.
Source:Jul 29, 2026, 00:00 UTC
Onconetix, Inc. entered into a committed equity facility agreement allowing it to sell up to $750 million of its common stock over time at prevailing market prices.
Jul 29, 2026, 00:00 UTC
Onconetix, Inc. signed a securities purchase agreement for a $30,249,600 Series F PIPE financing, issuing 37,812 shares of Series F convertible preferred stock at $1,000 per share.